Matrix Metalloproteinases and Glaucoma

Biomolecules. 2022 Sep 25;12(10):1368. doi: 10.3390/biom12101368.

Abstract

Matrix metalloproteinases (MMPs) are enzymes that decompose extracellular matrix (ECM) proteins. MMPs are thought to play important roles in cellular processes, such as cell proliferation, differentiation, angiogenesis, migration, apoptosis, and host defense. MMPs are distributed in almost all intraocular tissues and are involved in physiological and pathological mechanisms of the eye. MMPs are also associated with glaucoma, a progressive neurodegenerative disease of the eyes. MMP activity affects intraocular pressure control and apoptosis of retinal ganglion cells, which are the pathological mechanisms of glaucoma. It also affects the risk of glaucoma development based on genetic pleomorphism. In addition, MMPs may affect the treatment outcomes of glaucoma, including the success rate of surgical treatment and side effects on the ocular surface due to glaucoma medications. This review discusses the various relationships between MMP and glaucoma.

Keywords: genetics; glaucoma; matrix metalloproteinases; ocular surface; trabecular meshwork; wound healing.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Extracellular Matrix / metabolism
  • Glaucoma* / metabolism
  • Humans
  • Intraocular Pressure
  • Matrix Metalloproteinases / metabolism
  • Neurodegenerative Diseases* / metabolism
  • Retinal Ganglion Cells / metabolism

Substances

  • Matrix Metalloproteinases

Grants and funding

This study was supported by a VHS Medical Center Research Grant, Republic of Korea (Grant number: VHSMC 22017, Recipient: S.-H.L.). The funding organization had no role in the design or conduct of this study.